Treatment of Diuretic Resistance with a Novel Percutaneous Blood Flow Regulator: Concept and Initial Experience

J Card Fail. 2019 Nov;25(11):932-934. doi: 10.1016/j.cardfail.2019.08.017. Epub 2019 Aug 30.

Abstract

Diuretic resistance in acute heart failure is a common clinical problem, and it is associated with adverse outcomes. Effective therapies are still lacking. The Doraya catheter, a temporary intravenous flow regulator placed in the inferior vena cava below the level of the renal veins, is a novel device designed to target renal and cardiac congestion, thereby improving diuretic response. A first-in-man clinical study is currently ongoing.

Keywords: Acute heart failure; device therapy; diuretic resistance.

MeSH terms

  • Aged, 80 and over
  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology*
  • Cardiac Catheterization / methods*
  • Diuretics / pharmacology
  • Diuretics / therapeutic use*
  • Drug Resistance / physiology
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Hemodynamics / drug effects
  • Hemodynamics / physiology*
  • Humans
  • Male
  • Middle Aged

Substances

  • Diuretics